Subscribe: Market Wire - Pharmaceuticals and Biotech: Drugs
http://img.marketwire.com/rss/mwPBDR.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announces  apr  april  cannabis  company  marketwired apr  marketwired april  marketwired  medical  new  otc pink  pleased announce 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Drugs

Marketwired - Drugs



Marketwired - Drugs



Last Build Date: Fri, 21 Apr 2017 16:26:30 EDT

Copyright: Copyright: (C) Marketwired
 



Med Ad News Recognizes Healthcare Communications Excellence At 2017 Manny Awards

Fri, 21 Apr 2017 15:27:14 EDT

LIVINGSTON, NJ--(Marketwired - April 21, 2017) - Med Ad News -- the leading pharmaceutical business and marketing publication -- announces the winners for the 2017 Manny Awards, celebrating the best in the healthcare communications industry. The black-tie gala affair occurred last night at Pier Sixty in New York City with 500-plus people in attendance. Twenty awards were bestowed throughout the night to healthcare agencies achieving excellence in various categories.




Canada's Licensed Producers Gear Up for Recreational Market -- CFN Media

Fri, 21 Apr 2017 12:30:00 EDT

SEATTLE, WA--(Marketwired - Apr 21, 2017) -  CFN Media Group ("CFN Media"), the leading agency and digital media network dedicated to legal cannabis, today announced publication of an article discussing Canada's upcoming legalization and some licensed producers that are poised to capitalize on the greatly expanded market. Companies discussed include Maple Leaf Green World (TSX VENTURE: MGW) (OTCQB: MGWFF), Emerald Health Therapeutics (TSX VENTURE: EMH), and Invicuts MD Strategies (TSX VENTURE: IMH) (OTC PINK: IVITF). Three licensed producers expected to go public in the next week or so are also discussed: ABcann Global (ABcann Medicinals), WeedMD, and Harvest One.




Cannabis Science Continues Expansions as it Negotiates to Acquire Two Medical Marijuana Dispensaries in Los Angeles, California; The Company Expects to Sign Closing Documents Shortly

Fri, 21 Apr 2017 12:12:22 EDT

CBIS Negotiates for Two Los Angeles, California Medical Marijuana Dispensaries Right Before the Global Health Catalyst Summit at Harvard




Clinical Ink Extends eCOA and Risk-Based Monitoring Capabilities

Fri, 21 Apr 2017 12:00:00 EDT

Latest SureSource(R) Release Expands eSource Functionality and Platform Interoperability




Rennova Health's Big South Fork Medical Center Moves Closer to Opening

Fri, 21 Apr 2017 08:30:00 EDT

WEST PALM BEACH, FL --(Marketwired - April 21, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that the Centers for Medicare and Medicaid Services (CMS) has concluded its review of the application submitted by its subsidiary Big South Fork Medical Center (Legal Name: Scott Community Hospital, Inc.) requesting enrollment in the Medicare program as a Hospital. CMS has confirmed that it has issued a recommendation for approval to the Tennessee State Agency and the CMS Regional Office (RO).




Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01

Fri, 21 Apr 2017 06:00:00 EDT

NOVATO, CA--(Marketwired - Apr 21, 2017) - Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to announce that the European Patent Office has allowed a key patent for TAM-01, a novel mTOR modulator, targeting unmet need in systemic lupus erythematosus (SLE). The patent, owned by the Buck Institute for Research on Aging and licensed exclusively to Mount Tam Biotechnologies, provides composition of matter protection for Mount Tam's lead compound in Europe, further strengthening Mount Tam's strong intellectual property position in the United States and Japan.




InMed Pharmaceuticals Announces Marketed Offering of Common Shares

Fri, 21 Apr 2017 05:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2017) -




Vernalis PLC: FDA Issues a Complete Response Letter on CCP-07 NDA

Fri, 21 Apr 2017 02:00:00 EDT

WINNERSH, UNITED KINGDOM--(Marketwired - Apr 21, 2017) - Vernalis PLC (LSE: VER)




Diet Doc Examines Troubling Trend of Illness-Based 'Flu Diet,' 'Cancer-Diet' and Others

Fri, 21 Apr 2017 01:00:00 EDT

LAS VEGAS, NV--(Marketwired - April 21, 2017) - Given how difficult the average weight loss journey can be, it's no wonder that many people go to extreme measures to lose weight fast. Normally such trends manifest themselves in fad dieting, very low-calorie consumption, meal replacements, juicing, fasting, etc. All these 'diets' have their own set of rules and you'd assume that if they actually worked, the industry wouldn't be producing so many versions of them over time. In fact, most of them trigger temporary, unsustainable weight loss, along with a multitude of additional side-effects such as hunger, binge eating, mood swings, heart palpitations, low-energy, nutritional deficiencies and a host of others.




TerrAscend Announces Filing of Final Prospectus and Closing of Non-Brokered Private Placement

Thu, 20 Apr 2017 17:07:42 EDT

TORONTO, ONTARIO--(Marketwired - April 20, 2017) -




Aevi Genomic Medicine Presents Updated Results from SAGA Trial of AEVI-001 at the 6th World Congress on ADHD

Thu, 20 Apr 2017 16:30:00 EDT

PHILADELPHIA, PA--(Marketwired - Apr 20, 2017) -




Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension

Thu, 20 Apr 2017 16:22:45 EDT

VANCOUVER, BC--(Marketwired - April 20, 2017) - Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) (XETRA: ZSB) announces an extension to the term of 8,850,770 common share purchase warrants (the "Warrants") originally issued on March 6, 2014. The warrants were issued as part of a private placement. The expiry dates will be extended as follows:




Avantor Acquires Puritan Products

Thu, 20 Apr 2017 15:30:00 EDT

Acquisition bolsters Avantor's portfolio of high-purity cGMP materials and solutions for Biopharma, Research and Electronic Materials customers




World's Largest Society for Regulatory Professionals Increases Investment in Europe

Thu, 20 Apr 2017 14:00:30 EDT

ROCKVILLE, MD and NEWCASTLE UPON TYNE, UNITED KINGDOM--(Marketwired - April 20, 2017) - The Regulatory Affairs Professionals Society (RAPS) is stepping up its presence in Europe and expanding its European team in response to growing membership demand from those involved with the regulation of healthcare and related products.




Worlds Online Reports 2016 Revenue Increase of 180% From Cannabis Business

Thu, 20 Apr 2017 13:30:05 EDT

Total Assets Increase 130%




PotCircles Launches Team Member Video Application Process

Thu, 20 Apr 2017 13:17:55 EDT

LAS VEGAS, NV--(Marketwired - Apr 20, 2017) -  PotCircles is a project of South American Gold Corp (OTC PINK: SAGD). Individuals wishing to apply for one of many positions coming available should create a video application and submit it at www.potcircles.com/submitvideo.




FutureLand Corp (FUTL) Joins the National Cannabis Industry Association (NCIA)

Thu, 20 Apr 2017 13:14:27 EDT

DENVER, CO--(Marketwired - Apr 20, 2017) - FutureLand Corp. (OTCQB: FUTL), a dynamic growth company in the cannabis sector, announced today that it has joined the National Cannabis Industry Association (NCIA).




VANC Pharmaceuticals Appointment of Mr. Alan Arnstein to its Board of Directors

Thu, 20 Apr 2017 13:06:09 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 20, 2017) - VANC Pharmaceuticals Inc. (TSX VENTURE:VANC)(OTCQB:NUVPD) ("VANC" or the "Company"), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets is pleased to announce the appointment of Mr. Alan Arnstein to VANC's Board of Directors.




Former Megaupload Programming Team Joins mCig, Inc. in the Cannabis Tech Space

Thu, 20 Apr 2017 12:17:53 EDT

HENDERSON, NV--(Marketwired - Apr 20, 2017) - mCig, Inc., (OTCQB: MCIG) a leading distributor of innovative products, technologies and services for the global medical marijuana industry, is pleased to announce the achievement of acquiring part of the former Megaupload development team. The team is led by Chief Technologist, Andrus Nomm, recognized as the senior operative and programming lead in the popular online file sharing, streaming and ad serving websites of MEGAupload, MEGAclick and MEGAvideo. The sites served approximately 50 million users per day over 6500+ servers, monetizing over a quarter billion USD in advertising and subscription revenue. 




New Colombia Resources Inc. Announces Medical Marijuana Producer Sannabis is First to Pay Colombia's New Cannabis Tax

Thu, 20 Apr 2017 12:01:11 EDT

Company to be applying for cultivation licenses by April 28




Ogilvy CommonHealth Worldwide strengthens its creative offering with executive-level new hire and promotions

Thu, 20 Apr 2017 11:26:36 EDT

PARSIPPANY, NJ--(Marketwired - Apr 20, 2017) - Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com) and a WPP Health & Wellness company (NASDAQ: WPPGY) (www.wpp.com), today announced one new hire and three promotions at the executive vice president, creative director level in the network's New Jersey headquarters.




Cannabis Science Issues First Quarter Update and Celebrates 4/20 With Unprecedented Revenue Growth Projections and Sustainable Equity Value Looking Forward to More Quarterly Growth and Progress Reports

Thu, 20 Apr 2017 11:18:02 EDT

IRVINE, CA--(Marketwired - Apr 20, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, recently announced a pending offering memorandum for expansion capital, another large drug development deal, and an expedited seeding schedule, all of which are expected to create sustainable equity value and unprecedented revenue growth for the company.




Hemp industry sales grow to $688 Million in 2016, reports Hemp Business Journal

Thu, 20 Apr 2017 10:27:19 EDT

DENVER, CO--(Marketwired - Apr 20, 2017) - Hemp Business Journal, the leading provider of data and market intelligence for the hemp industry, has published estimates of the size of the 2016 U.S. retail market for hemp products.




Agritek Holdings, Inc. Announces Purchase Of 420 Style Bud And Breakfast Resort In Quebec, Canada As New Recreational Regulations Set To Pass In Canada

Thu, 20 Apr 2017 10:13:14 EDT

Company To Purchase Fifteen-Acre Resort And Estate Property In Canada Where Guests Can Enjoy Cannabis Friendly Atmosphere and Multiple Amenities




Propanc CEO James Nathanielsz's FDA Policy Proposals Published in Pharma Trade Media

Thu, 20 Apr 2017 10:07:05 EDT

Company completes 1-for-250 reverse split and name change to Propanc Biopharma Inc.




OncBioMune Licenses Tretinoin for the Treatment of Acute Promyelocytic Leukemia Throughout Mexico, Central and Latin America

Thu, 20 Apr 2017 09:31:40 EDT

BATON ROUGE, LA--(Marketwired - April 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, is pleased to announce the signing of a licensing agreement between the Company and PROCAPS S.A.S. granting OncBioMune rights to tretinoin, also known as all-trans retinoic acid (ATRA), an oral drug for the treatment of Acute Promyelocytic Leukemia (APL), throughout Mexico, Central America and Latin America.




Aphria Raises $100 Million to Fund Continued Expansion of Production Capacity and Other Strategic Opportunities

Thu, 20 Apr 2017 09:15:21 EDT

LEAMINGTON, ONTARIO--(Marketwired - April 20, 2017) -




The New Texas Oil is Green Gold -- Southwest Cannabis Conference & Expo

Thu, 20 Apr 2017 09:09:54 EDT

FORT WORTH, TX--(Marketwired - Apr 20, 2017) - NFL players, patients, doctors, taxpayers, entrepreneurs, cultivators, media, job seekers, policy makers and other curious citizens gather in Fort Worth at the Southwest Cannabis Conference & Expo to proclaim cannabis is medicine. The event, scheduled for April 21-23, will be held at the Fort Worth Conference Center.




AlumiFuel Announces Plans for Cannabis Grow Facility

Thu, 20 Apr 2017 09:00:00 EDT

CENTENNIAL, CO--(Marketwired - Apr 20, 2017) - AlumiFuel Power Corporation (OTC PINK: AFPW) ("AlumiFuel" or the "Company") today announced that it has entered into negotiations, via an unaffiliated third party, for the launch and operation of a cannabis grow facility.




MyDx Releases Earnings Call Investor Presentation

Thu, 20 Apr 2017 09:00:00 EDT

Invites Industry and Media to Learn More About MyDx Breakthrough Technology Setting the Foundation for the Future of Cannabis




Freedom Leaf, Inc. (OTC PINK: FRLF) Today Announced Mr. Charles Grigsby Has Joined The Marijuana Legalization Company As Its New Chief Financial Officer

Thu, 20 Apr 2017 08:30:00 EDT

Freedom Leaf Executives Complete Trips to Vancouver, Spain, Israel, Germany, Netherlands to Outline Plans for Domestic and International Growth




Quadron Receives $305,000 Order for its Cannabis Oil Vape Pen Units and Cartridges

Thu, 20 Apr 2017 08:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 20, 2017) - Quadron Capital Corporation (the "Company" or "Quadron") - (CSE:QCC)(CSE:QCC.CN) is pleased to announce that it has received a $305,000 CDN order for its custom branded vape pen units and cartridges, marking the largest order for its vape pen units to date.




Atossa Genetics Receives Positive Interim Review From Independent Safety Committee in Phase 1 Endoxifen Dose Escalation Study

Thu, 20 Apr 2017 08:15:00 EDT

SEATTLE, WA--(Marketwired - Apr 20, 2017) -  Atossa Genetics, Inc. (NASDAQ: ATOS), a clinical-stage pharmaceutical company, today announced that it has received a positive interim review on its Phase 1 study of endoxifen, which is an active metabolite of the FDA approved drug tamoxifen, which is indicated for breast cancer and breast cancer prevention in high risk patients. The Independent Safety Committee reviewed the blinded data generated from the first cohort of the study (8 subjects) and concluded that the study may advance to the next dosing level.




Vitality Biopharma Releases Clinical Report of Cannabinoid Therapy for Pediatric IBD

Thu, 20 Apr 2017 08:00:00 EDT

Cannabinoid therapy was able to successfully induce and maintain long-term remission in case study of drug-resistant pediatric inflammatory bowel disease




Easton Pharmaceuticals Announces Signing Of Purchase Agreement Completing The Acquisition Of Revenue Producing Vaporizer and e-Liquids Manufacturer iBliss, Inc.

Thu, 20 Apr 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - Apr 20, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce the execution of final agreement completing the 100% acquisition of revenue generating vaporizer and e-liquids manufacturer, iBliss Inc. and its holding company.




Aldeyra Therapeutics, Inc. Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-102 in Sjögren-Larsson Syndrome

Thu, 20 Apr 2017 08:00:00 EDT

LEXINGTON, MA--(Marketwired - Apr 20, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a clinical-stage biotech company devoted to treating diseases thought to be related to endogenous aldehydes, a naturally occurring class of pro-inflammatory and toxic molecules, today announced that the United States Food and Drug Administration (FDA) has granted Aldeyra's novel compound ADX-102 orphan drug designation for the treatment of congenital ichthyosis, a severe skin disease characteristic of Sjögren-Larsson Syndrome (SLS). There are no FDA-approved therapies specifically indicated for the treatment of SLS, and ADX-102 is believed to be the only potential SLS therapy in clinical development.




Glybera Marketing Authorization Application Withdrawn In Europe and Other Selected Countries

Thu, 20 Apr 2017 08:00:00 EDT

PARMA, ITALY--(Marketwired - April 20, 2017) - Chiesi Farmaceutici Spa ("Chiesi") acknowledges that uniQure biopharma B.V (uniQure), have taken the decision to withdraw the ongoing application for the Marketing Authorization Renewal of Glybera, for which Chiesi holds commercialization rights for Europe and other selected countries. This request for withdrawal, which is taken unilaterally by uniQure, has not been triggered by grounds on quality, safety and/or efficacy of the product but it is associated with uniQure's own economic considerations.




The New Gold Standards of IRT Delivery for Clinical Trials, New Webinar Hosted by Xtalks

Thu, 20 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 20, 2017) - In a live presentation, Grant Dietrich, industry expert and Vice President of Strategic Partnerships at YPrime will discuss how emerging IRT system functionality goes beyond management of patient randomization and drug supply.




SGD Holdings, Ltd. Executes Build to Suit Lease Agreement on Three Acres for the Construction of a Cannabis Processing and Extraction Facility

Thu, 20 Apr 2017 07:20:01 EDT

VENTURA, CA--(Marketwired - Apr 20, 2017) -  SGD Holdings, Ltd (OTC PINK: SGDH) has signed a Five Year Sub-Lease Agreement including multiple 3 year options for a three acre lot from CannaGrow Holdings, Inc. (OTC PINK: CGRW) on the same parcel as their Colorado Buffalo Ranch Grow Facility.




CannaRoyalty Launches The Terpistry in Collaboration with Dr. Jorg Bohlmann

Thu, 20 Apr 2017 07:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - April 20, 2017) - CannaRoyalty Corp. (CSE:CRZ)(CSE:CRZ.CN)(OTCQB:CNNRF) ("CannaRoyalty" or the "Company") announced the launch of "The Terpistry" in collaboration with Dr. Jörg Bohlmann, a world recognized leader in terpene profiling. Dr. Bohlmann brings extensive expertise in terpenoids, terpene synthases, terpenoids-cannabinoids relationship, and formulation. The Terpistry, a wholly-owned venture of CannaRoyalty, will focus on the development and sale of cannabis products with innovative terpene formulations.




HempLife Today Celebrates 420 and Rewards Its Growing Customer Base With its Biggest Sale of the Year

Thu, 20 Apr 2017 07:00:00 EDT

DENVER, CO--(Marketwired - Apr 20, 2017) - Ubiquitech Software Corp. (OTC PINK: UBQU), through its subsidiary HempLife TodayT an innovative and growing Company offering the finest CBD (Cannabidiol), products derived from Hemp, is celebrating 420 and rewarding its customers by offering its largest semi-annual discount on all of its CannazALLT CBD products.




New Frontier Data & MassRoots Partner on First Cannabis Consumer Sentiment Report

Thu, 20 Apr 2017 07:00:00 EDT

WASHINGTON, DC--(Marketwired - April 20, 2017) - New Frontier Data, the authority in business intelligence for the cannabis industry, and MassRoots, Inc. (OTCQB: MSRT), one of the leading publicly-traded cannabis technology companies, are partnering to craft a first of its kind report which will extract business intelligence from cannabis consumer data.




CannaGrow Holdings Announces a New Build to Suit Sub-Lease With Tenant at Colorado Buffalo Ranch

Thu, 20 Apr 2017 06:30:00 EDT

GREENWOOD VILLAGE, CO--(Marketwired - Apr 20, 2017) - CannaGrow Holdings, Inc. (OTC PINK: CGRW) - As a Liaison and Consultant providing turnkey solutions to licensed growers, CannaGrow Holdings, Inc. announces the execution of a Build to Suit Sub-Lease for an Extraction/Processing Facility with SGD Holdings, Ltd. (OTC PINK: SGDH) on a three (3) acre lot at their Colorado Buffalo Ranch Filing No. 5-Lot 61 Lease.




Applied DNA Sciences Signs 5-Year Supply Agreement for Bulk DNA Manufacturing

Thu, 20 Apr 2017 05:30:00 EDT

Agreement Highlights Growth Opportunity for Company's Proprietary DNA Production Technology




SPYRUS(R) Announces Hardware "Root of Trust" Product Family Supporting Microsoft Azure IoT Hub

Thu, 20 Apr 2017 03:01:00 EDT

SPYRUS FIPS 140-2 Level 3 Certified Devices Bring Strong Authentication to SAS Token and TLS/SSL Schema Azure IoT Hub




Diet Doc's Comprehensive Weight Loss Program Surpasses Military Diet Results

Thu, 20 Apr 2017 01:00:00 EDT

MONTGOMERY, AL--(Marketwired - April 20, 2017) - The Military Diet claims rapid weight loss results for individuals who have the military-style discipline to adhere to its strict guidelines. The official website says that people can lose up to 10 pounds each week without the help of exercise or supplements. It consists of very low-calorie foods that work together in order to activate weight loss. The Military Diet is an attractive option, given that one only needs to adhere to its low-calorie meal plans for 3 out of 7 days; leaving dieters the option of eating whatever else they want during the other four days.




Cosmos Holdings, Inc. Announces Full-Year 2016 Results

Wed, 19 Apr 2017 17:58:23 EDT

Revenue Improved 1,166 Percent and Gross Profit Improved 1,126 Percent Year over Year




Napoli Shkolnik to Appear Before The United States Supreme Court

Wed, 19 Apr 2017 16:00:10 EDT

The issue being heard is a challenge to the California Supreme Court's decision that out of state victims may sue in California




The Green Organic Dutchman Holdings Ltd. Closing of $28,350,567 Million Offering

Wed, 19 Apr 2017 14:40:27 EDT

HAMILTON, ON--(Marketwired - April 19, 2017) - The Green Organic Dutchman Holdings Ltd. (the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement on March 24th, which was upsized from C$10,000,000 to C$21,957,984 due to increased demand.




Cannabis Science Senior Executives Set to Present Drug Development Initiatives to Key Stakeholders Around the World at the Upcoming Global Health Catalyst Summit at Harvard Medical School Next Week, April 28 - 30th 2017

Wed, 19 Apr 2017 13:03:01 EDT

Cannabis Science Versus Cancer and Other Malignancies and the Palliative Care and Mental Health Sessions will be live-streamed to an audience worldwide




Parvus Therapeutics Announces Exclusive Worldwide License and Collaboration Agreement for the Development and Commercialization of Its Lead Nanomedicine to Treat Type 1 Diabetes

Wed, 19 Apr 2017 12:00:00 EDT

CALGARY, AB--(Marketwired - April 19, 2017) - Parvus Therapeutics, a biopharmaceutical company developing disease-modifying nanomedicines to halt or reverse autoimmune disease without causing general immune suppression, has entered into a license and collaboration agreement with Novartis for its lead Navacim for treating type 1 diabetes. Navacims constitute a novel pharmacological class of therapeutic comprised of nanoparticles (NPs) coated with disease-relevant peptide-major histocompatibility complexes (pMHCs) that alter the behavior of disease-causing T lymphocytes. Navacims are the first biopharmaceuticals to demonstrate in preclinical models the ability to restore immune tolerance in a disease-specific manner through in vivo formation and expansion of regulatory T-cells (T-regs) without causing general immune suppression.




ViaDerma, Inc. Announces its President, Dr. Christopher Otiko's Abstract was Well Received at the DFCON Conference as the Company Completes Final Testing for its FDA Registered Viabecline for Manufacturing in the Next Several Weeks

Wed, 19 Apr 2017 11:30:00 EDT

The Company is in the Final Phase of Testing its Proprietary Viabecline Formula for Manufacturing over the Next few Weeks and once Completed Will Start Manufacturing the Product for Distribution and Sales




Marijuana Company of America Announces Formation of Strategic Advisory Board

Wed, 19 Apr 2017 11:11:23 EDT

BONSALL, CA--(Marketwired - Apr 19, 2017) - Marijuana Company of America ("MCOA" or "the Company") (OTC PINK: MCOA), an innovative cannabis and marketing company, has established a Strategic Advisory Board, with the appointment of Noble DraKoln as Chairman, and the appointment of Andy Carter and David Hill as Advisors.




Robot Automates Major Lab's Test in Unexpected Way

Wed, 19 Apr 2017 09:30:00 EDT

SALT LAKE CITY, UT--(Marketwired - April 19, 2017) - A new machine/robot called the Data Matrix Scanner is going to automate a lab's procedures to test for cholesterol particles at high volume and without the messy turns and pitches of human error. This is no ordinary solution -- it is a story of solving technological challenges in modern laboratory medicine for an important test. ARUP Laboratories needed a unique fix to move that test in-house, photograph in one shot 96 test tubes on a tray with their accompanying tiny barcodes, and process 3,000 test tubes a month while tracking the number and ID for each. So lab supervisors and in-house engineers worked out their needs and had it built.




Lotus Ventures Inc.: Cannabis Facility Permits Issued

Wed, 19 Apr 2017 09:30:00 EDT

VANCOUVER, BC--(Marketwired - April 19, 2017) - Lotus Ventures Inc. (CNSX: J) is pleased to report that its activities to obtain Licensed Producer (LP) status under the Health Canada, Access To Cannabis For Medical Purposes Regulations (ACMPR) has moved forward and we are poised to begin construction of the first facility in 2017.




Plandai Biotechnology Sets Aggressive Agenda for 2017

Wed, 19 Apr 2017 09:00:00 EDT

NEW YORK, NY--(Marketwired - April 19, 2017) - Plandaí Biotechnology (OTCQB: PLPL) recently presented investors with its outlook for 2017 and a number of milestones that the company plans to accomplish in 2017. Plandaí's plans are certainly aggressive and representative of the new Chief Operating Officer (COO) -- someone we feel is ideally suited to move the company forward. It didn't take long at all for the new COO, Callum Cottrell-Duffield, to put his stamp on the company's future.




Desert Oasis Healthcare Establishes Center for Research and Healthcare Innovation Featuring Altura's HCP Studies(TM) Mobile Platform

Wed, 19 Apr 2017 08:30:00 EDT

Altura's Novel Study Engagement Platform(TM) to Help Create Optimized Clinical Study Ecosystem for Patients and Healthcare Providers




NetworkNewsWire Announces Publication Highlighting Advances in Cancer Therapy

Wed, 19 Apr 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Apr 19, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring TapImmune, Inc. (NASDAQ: TPIV), an NNW client focused on leading the field of oncology with its next-generation T-cell vaccines and novel immunotherapy platforms.




Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec

Wed, 19 Apr 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - April 19, 2017) - Tetra Bio-Pharma Inc. ("Tetra") (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) and Aphria Inc. ("Aphria") (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.




InfinityQS Launches Enact -- the Future of Manufacturing Quality

Wed, 19 Apr 2017 08:00:00 EDT

Enact Quality Intelligence platform redefines quality with unparalleled visibility and operational insight, creating a key gateway for manufacturing Industry 4.0 and the Industrial Internet of Things




Endexx Begins Shipment of Third Eye Chai CBD-Infused Gourmet Tea Beverages

Wed, 19 Apr 2017 08:00:00 EDT

Partnership with The Mad Hatter Coffee & Tea Co. to Tap into $47 Billion Global Tea Market




Canabo Opens Clinic in Kelowna, BC and Provides Update on Peak Medical Group

Wed, 19 Apr 2017 08:00:00 EDT

KELOWNA, BC--(Marketwired - April 19, 2017) - Canabo Medical Inc. (TSX VENTURE: CMM) (OTCQB: CAMDF) ("Canabo" or the "Company") is pleased to announce it has opened its 16th clinic in Kelowna, British Columbia. The Kelowna clinic is located in the Sterling Centre at 3975 Lakeshore Road, and will be led by Dr. Chemanthi Kalen.




Lion Biotechnologies Announces Strategic Alliance with MD Anderson Cancer Center to Conduct Clinical Trials of TILs in Multiple Solid Tumors

Wed, 19 Apr 2017 08:00:00 EDT

SAN CARLOS, CA and HOUSTON, TX--(Marketwired - April 19, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology and The University of Texas MD Anderson Cancer Center, today announced a multi-year strategic alliance agreement involving multi-arm clinical trials to evaluate the safety and efficacy of TIL therapy in ovarian cancer, various sarcomas, and pancreatic cancer. In addition, preclinical research will explore the expansion of TIL in other rare tumor types.




Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec

Wed, 19 Apr 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - April 19, 2017) - Tetra Bio-Pharma Inc. ("Tetra") (CSE:TBP) (OTCQB:GRPOF) and Aphria Inc. ("Aphria") (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.




Technology Solutions for Late Phase Research: Optimizing Real World Data Assets, New Webinar Hosted by Xtalks

Wed, 19 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 19, 2017) - Michael Cook, Principal of Epidemiology and Bill Row, Divisional Principal of Real World Evidence both from ICON Commercialisation and Outcomes will outline how technological innovation can be applied to late phase research studies and how the smart application of that technology can enhance use of real world data (RWD) assets. The live event will take place on Monday, May 1, 2017 at 11am EDT (4pm BST/UK).




Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter

Wed, 19 Apr 2017 07:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - Apr 19, 2017) - Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that it is delaying the filing of its Annual Report on Form 10-K for the year ended December 31, 2016 ("Form 10-K").




ContraFect to Present New Data at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID)

Wed, 19 Apr 2017 07:00:00 EDT

YONKERS, NY--(Marketwired - April 19, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announces the presentation of new data from its Phase 1 CF-301 study at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) to be held on April 22-25, 2017 in Vienna, Austria.




Diet Doc Advises Unless You Have a Gluten Allergy, Gluten-Free Dieting May do More Harm Than Good

Wed, 19 Apr 2017 01:00:00 EDT

PORTLAND, OR--(Marketwired - April 19, 2017) - Dietary restrictions are almost always thought of as a means of losing weight, or fostering a healthier lifestyle. Most consumers assume that the term 'diet' automatically corresponds with improving one's wellness. The gluten-free diet falls into this category, as many assume that avoiding gluten offers health benefits, including weight loss. However, Diet Doc's Medical Director, Dr. Nishant Rao, wants to remind consumers that going gluten-free without having a gluten allergy might ultimately do more harm than good.




Cannada Market is Canada's First Licensed Mail Order Marijuana Company Dedicated to Craft Cannabis

Tue, 18 Apr 2017 17:50:01 EDT

VICTORIA, BRITISH COLUMBIA--(Marketwired - April 18, 2017) - CannadaMarket.com is pleased to announce it has been granted a cannabis business license from the City of Victoria to operate its Ebay style marijuana marketplace-home to the top craft producers in Canada and the Original 420 Auction.




OncBioMune Prepares Submission Seeking Marketing Approval for Anti-D Immunoglobulin in Mexico

Tue, 18 Apr 2017 15:10:44 EDT

BATON ROUGE, LA--(Marketwired - April 18, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, is pleased to announce the upcoming submission of the Anti-D immunoglobulin product marketed as KamRho® by Kamada and licensed by OncBioMune for the Mexican market. Documentation is being finalized with submission to COFEPRIS, Mexico's equivalent of the U.S. Food and Drug Administration, expected by the end of the month. Anti-D immunoglobulin is listed on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.




Non-Profit MAPS to Utilize Full Range of Medrio Functionality for Pivotal PTSD Study

Tue, 18 Apr 2017 12:00:00 EDT

SAN FRANCISCO, CA--(Marketwired - April 18, 2017) - The Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based non-profit research organization, has selected Medrio, a Software as a Service (SaaS) company offering electronic data capture services to clinical trials, as its data management system for a Phase 3 clinical trial testing the efficacy and safety of MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD). MAPS has utilized Medrio for its research in the past, but the new agreement represents its first purchase of the full range of modules in Medrio's software, including eSource, randomization, dictionary coding, and others. The agreement will commence in 2018 and remain in place until 2020. In preparation for the Phase 3 studies, MAPS is currently hosting their Phase 3 Investigator Meeting in Oakland, CA.




Bradmer Announces Fourth Quarter and Full Year 2016 Financial Results

Tue, 18 Apr 2017 11:46:08 EDT

TORONTO, ONTARIO--(Marketwired - April 18, 2017) - Bradmer Pharmaceuticals Inc. (NEX:BMR.H) ("Bradmer" or the "Company") today announced its fourth quarter and full year 2016 financial results.




Tokyo Smoke partners with Partisans to reimagine the classic cannabis pipe

Tue, 18 Apr 2017 09:30:00 EDT

TORONTO, ON--(Marketwired - April 18, 2017) - Tokyo Smoke has partnered with Partisans, the world-renowned architecture and design firm behind Bar Raval and the Grotto Sauna, to reimagine the classic pipe, creating two wholly innovative takes on the ubiquitous cannabis accessory. Widely regarded as the destination for impeccably designed smoking products, Tokyo Smoke's collaboration with Partisans marks its next step in elevating the smoking experience and pushing the boundaries of the industry. The Io Water Pipe and the Crater Pipe demonstrate how cannabis products can combine art and functionality. Created using 3D printers, the pipes are a conceptual, functional and aesthetic take on the pipe or bong and are rendered in either porcelain or stainless steel. Launching just in time for 4/20, the products will be available at Tokyo Smoke retail locations and online.




NIH/NCATS and InSphero Host Inaugural 3D Tumor Model Standards Working Group at AACR 2017

Tue, 18 Apr 2017 09:30:00 EDT

Establishing standards for next-generation tumor models to benefit drug discovery and broader research community primary objective of new group




Advantis Corp. Set To File for California Commercial Distribution License

Tue, 18 Apr 2017 09:28:00 EDT

NEWPORT BEACH, CA--(Marketwired - Apr 18, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) filed paperwork in California last week as a first step toward applying for commercial recreational marijuana distribution license. Advantis CEO, Christopher Swartz, says the company is preparing to be "first in line" once the state sets the recreational licensing process in motion.




MyDx Announces Fiscal Year 2016 Results

Tue, 18 Apr 2017 09:20:00 EDT

SAN DIEGO, CA--(Marketwired - Apr 18, 2017) -  MyDx, Inc. (OTCQB: MYDX), a rapidly growing science and technology company that has developed MyDx®, the first multi-use handheld chemical analyzer for consumers, announces its 2016 fiscal year earnings results and management analysis. 




Proto Script Pharmaceutical Signs Medical Equipment Supply Agreement with PAKmed

Tue, 18 Apr 2017 09:03:05 EDT

RANCHO CUCAMONGA, CA--(Marketwired - Apr 18, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, is pleased to announce that the Company has entered into a Supply Agreement with PAKmed LLC ("PAKmed"), a manufacturer of premium orthotic braces based in Louisville, Kentucky.




eWellness Plans the Launching of Multiple New Patient, Physician & PT Centric Platforms and Mobile Apps

Tue, 18 Apr 2017 09:00:00 EDT

CULVER CITY, CA--(Marketwired - Apr 18, 2017) - eWellness Healthcare Corporation - (OTCQB: EWLL), a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it plans to launch multiple new patient, physician and physical therapy (PT) centric platforms and mobile Apps over the next 8-10 weeks.




Sandoz Canada lance Mosaspray(MC) au Québec, mométasone en vaporisateur nasal sans ordonnance pour soulager les symptômes de la rhinite allergique

Tue, 18 Apr 2017 09:00:00 EDT

BOUCHERVILLE, QC--(Marketwired - 18 avril 2017) - Sandoz Canada est heureuse d'annoncer le lancement, au Québec, de MosasprayMC (furoate de mométasone monohydraté), un vaporisateur nasal pour le soulagement des symptômes de la rhinite allergique saisonnière et ceux de la rhinite allergique apériodique pour les personnes âgées de 12 ans ou plus, maintenant disponible sans ordonnance, derrière le comptoir du pharmacien.




Sandoz Canada launches Mosaspray(TM) in Quebec: a non-prescription mometasone nasal spray for the treatment of the symptoms of allergic rhinitis

Tue, 18 Apr 2017 09:00:00 EDT

BOUCHERVILLE, QC--(Marketwired - April 18, 2017) - Sandoz Canada is pleased to announce the launch in Québec of MosasprayT (Mometasone Furoate Monohydrate), a nasal spray for the treatment of the symptoms of seasonal or perennial allergic rhinitis for people of 12 years of age or older, now available without a prescription, behind the pharmacy counter.




Medicine Man Technologies Files its 2016 Annual Report and Issues Revenue Guidance for Q1 2017

Tue, 18 Apr 2017 08:45:00 EDT

DENVER, CO--(Marketwired - Apr 18, 2017) - Medicine Man Technologies Inc. (OTCQB: MDCL), one of the country's leading cannabis branding and consulting companies, announced that the Company has filed its 2016 Annual Report on Form 10-K for the year ended December 31, 2016, and is providing guidance related to its first quarter 2017 performance.




South American Gold Takes Control of cNation

Tue, 18 Apr 2017 08:32:13 EDT

LAS VEGAS, NV--(Marketwired - Apr 18, 2017) - South American Gold Corp (OTC PINK: SAGD) is announcing that it has taken control of cNation, a cannabis focused social outlet.




Quadron Welcomes Canada's New Legislation Framework on Legalization of Cannabis

Tue, 18 Apr 2017 08:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 18, 2017) - Quadron Capital Corporation (the "Company" or "Quadron") (CSE:QCC)(CSE:QCC.CN) welcomes the federal government's introduction of a regulatory framework to legalize the adult use of cannabis.




American Cannabis Company, Inc. Announces a New Client and License Applicant in Louisiana

Tue, 18 Apr 2017 08:30:00 EDT

DENVER, CO--(Marketwired - Apr 18, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) (the "Company"), a business-to-business consulting firm and distributor of ancillary products and services to the cannabis industry, today announced it has secured its first retainer client (the "Client") in the state of Louisiana. The Client, CB Medical, LLC ("CB Medical"), is a newly formed entity that is one of the applicants for the LSU-sponsored medical marijuana program. LSU has indicated that it will select finalists for live presentations next month, and then it will determine a winner in June 2017.




Reading Health System Continues to Align and Engage Its Physician Leaders by Expanding the Reach of the Applied Physician Leadership Academy(C)

Tue, 18 Apr 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Apr 18, 2017) - Reading Health System, in conjunction with The Leadership Development Group, is changing its culture by focusing on physician leadership, alignment, and engagement. This month twenty-eight of the top ranked physician leaders from Reading Health System (RHS) graduated from The Leadership Development Group's Applied Physician Leadership Academy (APLA©), an 18-month customized leadership development program, designed to engage and develop physician leaders. And in January 2017, twenty-six emerging physician leaders joined together from across the organization to kick off a second cohort of the APLA that will run through March 2018. The program, intended to engage, inspire, and motivate leadership development for physicians, includes structured training courses focusing on development of leadership skills and competencies; mentoring and networking, assessments, coaching and feedback; and the process to apply learning and develop leadership competencies through work on real business problems.




Lexaria Welcomes Canada's Proposed Cannabis Legislation

Tue, 18 Apr 2017 08:05:00 EDT

KELOWNA, BC--(Marketwired - April 18, 2017) - Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (the "Company", "Lexaria") welcomes the newly proposed Canadian legislation designed to allow for adult legal access to Cannabis (the "Cannabis Act"). In line with the Cannabis Act's objective to protect public health and public safety, powerful demographic and lifestyle forces are trending away from both the harmful effects related to inhalational dosing (smoking/vaping) and from edibles with high sugar & fat content.




Pharmaceutical Industry Executive Brian W. Andersen Named Chief Business Officer at Asana Medical, Inc.

Tue, 18 Apr 2017 08:00:00 EDT

MIAMI LAKES, FL--(Marketwired - Apr 18, 2017) - Asana Medical, Inc., ("Asana," the "Company"), a regenerative medicine company that is developing a novel treatment for Inflammatory Bowel Disease ("IBD"), including Ulcerative Colitis and Crohn's Disease, is pleased to announce that Brian W. Andersen, an experienced industry executive with a proven record of commercial excellence, has been appointed as its Chief Business Officer.




Garlock to Exhibit at "Korea Pharm 2017"

Tue, 18 Apr 2017 08:00:00 EDT

PALMYRA, NY--(Marketwired - Apr 18, 2017) -




Lion Biotechnologies Highlights Publication of New Translational Data in Science for TIL Therapy for Treatment of Cervical Cancer

Tue, 18 Apr 2017 08:00:00 EDT

SAN CARLOS, CA--(Marketwired - April 18, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, highlighted today that a publication in the journal Science provided new translational data from a clinical trial of TIL therapy for the treatment of advanced metastatic cervical cancer conducted at the Surgery Branch of the National Cancer Institute (NCI). This trial has been supported in part by Lion under a Cooperative Research and Development Agreement (CRADA) with Dr. Steven Rosenberg, Chief of the Surgery Branch, National Cancer Institute (NCI), National Institutes of Health.




Si-Ware Systems Announces NeoSpectra Micro Development Kits

Tue, 18 Apr 2017 08:00:00 EDT

Development with NeoSpectra Micro Ushers in the Era of Universal Material Analysis




Aldeyra Therapeutics, Inc. Announces Last Patient Dosed in Allergic Conjunctivitis Phase 2b Clinical Trial

Tue, 18 Apr 2017 08:00:00 EDT

LEXINGTON, MA--(Marketwired - Apr 18, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused primarily on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes, today announced that the last patient has completed dosing in Aldeyra's multi-center, double-blind, randomized Phase 2b clinical trial of ADX-102 in allergic conjunctivitis. 




Stealth Mark Expands ActiveDuty's Power for Covert Ops

Tue, 18 Apr 2017 08:00:00 EDT

HOFFMAN ESTATES, IL--(Marketwired - Apr 18, 2017) - Wellness Center USA, Inc. (OTCQB: WCUI), today announced that its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, is expanding its anti-counterfeiting ActiveDuty System to provide actionable intelligence in the worlds of money laundering and human trafficking/slavery. The scope of the work is being conducted in collaboration with prominent organizations, and is classified in nature.




ICC Enters Into Importation Agreement With ARA - Avanti Rx Analytics

Tue, 18 Apr 2017 07:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 18, 2017) - ICC International Cannabis Corporation ("ICC" or the "Company") (TSX VENTURE:ICC) is pleased to announce that it has entered into an Importation Agreement with ARA - Avanti Rx Analytics Inc. ("Avanti"), a licensed dealer under the Controlled Drugs and Substances Act (Canada) and its regulations overseen by Health Canada.




Pharmaceutical Serialization for Late Starters -- With Live Industry Research Results from SEA Vision, New Webinar Hosted by Xtalks

Tue, 18 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 18, 2017) - In this live session, entitled 'pharmaceutical serialization for late starters', Carlos Machado, serialization director at SEA Vision US and Paolo Landriani, product manager at SEA Vision Italy will offer insight on how companies within the pharmaceutical industry can prepare for upcoming serialization regulations, with a view to guaranteeing long term success and compliance.




Nutritional High Announces Sale of FLI Cartridges to Nature's Herbs in Colorado

Tue, 18 Apr 2017 07:30:00 EDT

TORONTO, ONTARIO--(Marketwired - April 18, 2017) - Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT)(CSE:EAT.CN)(OTCQB:SPLIF)(FRANKFURT:2NU) is pleased to announce that Palo Verde LLC ("Palo Verde"), a company's licensed tenant in Colorado has filled a major order for Natures Herbs and Wellness Center in Colorado ("Natures Herbs").




Immunovaccine Announces Dosing of First Patient in Investigator-Sponsored Phase 1b/2 Clinical Trial Evaluating Immuno-Oncology Candidate Targeting Incurable HPV-Related Cancers

Tue, 18 Apr 2017 07:05:00 EDT

Study Demonstrates Broad Applicability of Immunovaccine's DepoVax(TM) Platform for Delivering Cancer Antigens




60-Second Liver assessment: SuperSonic Imagine will demonstrate the performance of Real-Time ShearWave(TM) Elastography at the upcoming International Liver Congress (ILC 2017) in Amsterdam

Tue, 18 Apr 2017 06:00:00 EDT

AIX-EN-PROVENCE, FRANCE--(Marketwired - Apr 18, 2017) - SuperSonic Imagine (EURONEXT PARIS: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will showcase the clinical benefits of its real-time ShearWaveT Elastography (SWET) technology for non-invasive assessment of patients with chronic liver disease at the International Liver Congress (ILC 2017) or EASL, April 19 - 23 in Amsterdam.




Diet Doc Discourages the Harmful Simeons hCG Diet and Recommends Higher Calorie Weight Loss Programs

Tue, 18 Apr 2017 01:00:00 EDT

PHOENIX, AZ--(Marketwired - April 18, 2017) - Millions of Americans are in search of the perfect weight loss solution, but finding and maintaining an effective diet is no easy task. Generally speaking, reducing 500 calories per day results in 1 to 2 pounds of weight loss per week. Dieters can lose weight faster if they combine a balanced diet with physical activity or medical weight loss solutions.




CaliPharms Enters Acquisition Discussions with California Cannabis Retailers, Inc.

Mon, 17 Apr 2017 20:05:46 EDT

RIVERSIDE, CA--(Marketwired - Apr 17, 2017) - CaliPharms, Inc. (OTC PINK: KGET), a Company operating in the California Medicinal Cannabis industry, publicly trading under the OTC Markets symbol "KGET" is pleased to announce that CaliPharms has entered into acquisition discussions with United Cannabis Retailers, Inc. United Cannabis Retailers, Inc. is a cannabis product development company entering unfulfilled market niches in the cannabis sector. UCR is rolling out their first conceptual product line Canna-Kitchen this year. UCR is focused on promoting its brands.




CBIS Pushes Up the Seeding Schedule Next Month to 350 Acres Set to Include Additional 100 Acres in Minden Carson Valley Property Along with the San Joaquin Valley Property for its Industrial Commercial Hemp Grow Initiatives

Mon, 17 Apr 2017 14:15:20 EDT

Bringing Outdoor Cultivation Ready Land to 15.2 Million Square Feet in California and Nevada for its Industrial Commercial Hemp Grow Initiatives